Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer

Determination of the HER2/neu (HER2) status in breast carcinoma has become necessary for the selection of breast cancer patients for trastuzumab therapy. Amplification of the gene analysed by fluorescence in situ hybridisation (FISH) or overexpression of the protein determined by immunohistochemistr...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnould, L, Denoux, Y, MacGrogan, G, Penault-Llorca, F, Fiche, M, Treilleux, I, Mathieu, M C, Vincent-Salomon, A, Vilain, M O, Couturier, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377115/
https://www.ncbi.nlm.nih.gov/pubmed/12771927
http://dx.doi.org/10.1038/sj.bjc.6600943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377115/
https://www.ncbi.nlm.nih.gov/pubmed/12771927
http://dx.doi.org/10.1038/sj.bjc.6600943

Ejemplares similares